Both in Pharmaceuticals
Contineum Therapeutics vs ARS Pharmaceuticals
Over the past year CTNM returned −2.7% and SPRY returned −54.7%; their daily moves had a correlation of 0.18.
CTNM −2.7% SPRY −54.7%Growth of $1, one year, split-adjusted
| Metric | CTNM | SPRY |
|---|---|---|
| Price | $11.50 | $4.40 |
| Market cap | $432.6M | $437.6M |
| Today | −9.66% | +6.54% |
| 1 month | −32.6% | −25.3% |
| 6 months | −7.7% | −43.7% |
| Year to date | +0.6% | −62.2% |
| 1 year | −3.5% | −55.1% |
| Revenue growth (YoY) | — | +114.2% |
| Gross margin | — | 61.8% |
| Net margin | — | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.7× |
| Net cash | $236.6M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 70.0% |
| Short % of float | 8.7% | 47.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).